Srinidi Mohan, Ph.D., associate professor in the School of Pharmacy, has been selected to present his poster, "A Novel Blood-Based Biomarker That Distinguishes Estrogen-Negative Solid Tumors In Patient Samples," at the 14th Annual Massachusetts Life Sciences Innovation (MALSI) Day on Thursday, July 22.
The event is the biggest day for life sciences startups and innovation in Massachusetts, bringing together scientists, post-docs, professors, entrepreneurs, innovators, and venture capitalists. It helps the broad scientific community identify resources, find mentors, and bolster entrepreneurism. MALSI provides the path for an academic idea to become a real-world diagnostic/therapeutic product.
Twenty poster applications on cutting-edge diagnostic and therapeutic technologies have been selected. Presenters are provided the opportunity to make a one-minute pitch to highlight their innovation or discovery.
Last year's winner, Concerto Biosciences, went on to raise a seed round of $1.5M.
Mohan recently received a second patent from the United States Patent and Trademark Office for his breakthrough methods and diagnostics for cancer detection and treatment monitoring. The method uses a marker in the blood to detect the presence of highly aggressive tumors and to help track cancer growth.
